LAKEWOOD, Colo. —  Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a diversified supplier of quality control instruments and consumables to highly regulated markets today announced the acquisition of Gyros Protein Technologies Holding AB (“GPT”).  GPT is headquartered in Uppsala, Sweden and is a leading provider of Immunoassay and Peptide Synthesis solutions […]

Matthews, N.C. – CEM Corporation today announced that it has entered into a definitive agreement to purchase the instrumentation lines of Intavis Bioanalytical Instruments AG, with headquarters in Cologne Germany. The acquisition allows CEM to strengthen its product offering in the Life Sciences for proteomics, in-situ hybridization and particularly in the field of peptide synthesis. […]

Warminster, PA SP Industries, Inc. (“SP”), a leading designer and manufacturer of state-of-the-art laboratory equipment, pharmaceutical fill-finish manufacturing solutions, laboratory supplies and glassware, announced today that it has acquired the assets of privately held i-Dositecno. Located in Mataro, Spain, i-Dositecno is a global provider of complete sterile filling lines for pharmaceutical, cosmetic and ophthalmic applications. […]

WILMINGTON, Mass.–Onto Innovation Inc. (NYSE: ONTO) today announced the successful completion on October 25, 2019 of the previously announced merger of equals between Nanometrics Incorporated and Rudolph Technologies, Inc. Headquartered in Wilmington, Massachusetts, Onto Innovation is expected to be the fourth largest semiconductor capital equipment supplier by revenue in the U.S. and a top 15 semiconductor equipment […]

WASHINGTON — Danaher Corporation (NYSE: DHR) today announced that it has signed an agreement to sell its label-free biomolecular characterization, chromatography hardware and resins, and microcarriers and particle validation standards businesses to Sartorius AG for approximately $750 million. The combined revenue of the businesses, which are part of Danaher’s Life Sciences segment, was approximately $140 million in 2018. Danaher […]

MILPITAS, Calif. & WILMINGTON, Mass.– Nanometrics Incorporated (NASDAQ: NANO) and Rudolph Technologies, Inc. (NYSE: RTEC), today announced that their combined company will be named Onto Innovation Inc., following the close of their previously announced merger of equals. The name Onto Innovation reflects the combined company’s anticipated focus on the future and exciting challenges ahead, highlighting […]

Acquisition of FloDesign Sonics marks next step in autologous manufacturing   Burlington, Massachusetts – MilliporeSigma today announced it has acquired FloDesign Sonics, of Wilbraham, Massachusetts,  developer of a unique acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing. Financial details were not disclosed. “Chimeric antigen receptor T cell therapies, or CAR-T for short, employs the […]

Bruker and Freiberg Instruments Establish Related EPR Supply Partnership FREIBERG, Germany — Bruker (Nasdaq: BRKR) today announced the acquisition of the Magnettech EPR business from Freiberg Instruments GmbH, and the establishment of a related, long-term EPR supply partnership with Freiberg Instruments.  Financial details of the transaction were not disclosed. Magnettech’s benchtop electron paramagnetic resonance (EPR) […]

BERWYN, Pa. and SARASOTA, Fla. – AMETEK, Inc. (NYSE: AME) today announced that it has signed a definitive agreement to acquire Gatan, a leading manufacturer of instrumentation and software used to enhance and extend the operation and performance of electron microscopes, from Roper Technologies, Inc. (NYSE: ROP) in an all-cash transaction valued at $925 million. Gatan is a pioneer in direct detection […]

(Seattle, WA) – Seattle biotech company NanoSurface Biomedical, Inc., a leading provider of biomimetic cell-based assay platforms and services, announced today that it has acquired Silene Biotech, a Seattle biotechnology company focused on stem cell banking and services. This acquisition expands NanoSurface’s capabilities in developing human stem cell-based platforms and technologies to accelerate the development […]